CBD products
CBD products · page 4
- CBD Market
Cannaray to drive brand awareness following successful fundraise
Blue Array will be assisting the company in its digital campaigns.
- CBD Market
The Happy Hemper: bringing CBD to your front door
Discover one couple’s mission to bring CBD to the masses through its subscription hampers.
- CBD Market
FSA adds thousands of additional CBD products to public list
Following backlash from the industry, close to 2,500 products have been added to the Food Standards Agency’s public list which grants preliminary approval for CBD products that meet the regulator’s criteria.
- CBD Market
CBD gummies market projected to reach £12.1bn by 2028
The surging popularity of CBD gummies will see the market segment grow at a CAGR of 28.3 per cent from 2021 to 2028.
- CBD Market
CBD brand to sponsor Chatsworth International Horse Trials
New London-based CBD brand will launch six new products for sports and active lifestyles.
- CBD Market
GSK shows interest in Cann Group’s CBD capsule
The multinational pharmaceutical company GlaxoSmithKline has entered into an evaluation agreement with medical cannabis research company Cann Group which could lead to the marketing and distribution of a new CBD delivery system in Australia.
- Uncategorized
Curaleaf to reach into Caribbean market
The company has entered into a new distribution agreement with WB Canna Co. & Wellness.
- CBD Market
CBD company Greenrise advances German position with new acquisition
Greenrise has acquired a majority interest in CannaCare Health.
- CBD Market
Quanna: breaking taboos, creating a brand and building a community
Dr Dmitry Loktionov discusses the UK’s first CBD-based sexual wellness company, Quanna.
- CBD Market
British Cannabis celebrates 310 products on FSA CBD list
The company now manufactures 9 per cent of all CBD food supplements legal to sell in the UK.
- CBD Market
CBD companies give positive response to UK product list
Publication of the list is “first step to a better regulated industry”.
- CBD Market
Mixed response from CBD industry to publication of FSA product list
The development has been described as both a “milestone” and a “monumental waste of time and money”.
